Abstract
A systematic review was conducted on adverse events (AEs) associated with the use of the duodenal-jejunal bypass liner (DJBL). PubMed, EMBASE, and Cochrane library were searched up to January 2018. The quality of reporting AEs was determined by the McHarm questionnaire and the risk of bias by the Newcastle-Ottawa scale. Thirty-eight studies were included. The comparability of the studies was low and the McHarm questionnaire showed incompleteness for most parameters in all studies. A total of 891 AEs were reported in 1056 patients. Thirty-three AEs (3.7%) were classified as severe, including hepatic abscess and esophageal perforation. The anchor of the DJBL caused or likely caused 85% of the SAEs. To improve the safety margin of the DJBL, adjustments to the anchoring system are needed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abu Dayyeh BK, Edmundowicz SA, Jonnalagadda S, et al. Endoscopic bariatric therapies. Gastrointest Endosc. 2015;81(5):1073–86.
De Luca M, Angrisani L, Himpens J, et al. Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2016;26(8):1659–96.
Di Cesare M, Bentham J, Stevens GA, et al. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016;387(10026):1377–96.
Zechmeister-Koss I, Huic M, Fischer S. The duodenal-jejunal bypass liner for the treatment of type 2 diabetes mellitus and/or obesity: a systematic review. Obes Surg. 2014;24(2):310–23.
Stolbova S, Benes M, Petruzelkova L, et al. For debate: should bariatric surgery be performed in children and adolescents with hypothalamic obesity? Pediatr Endocrinol Rev. 2017;14(4):348–52.
Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010;71(3):446–54.
Chou R, Aronson N, Atkins D, et al. AHRQ series paper 4: assessing harms when comparing medical interventions: AHRQ and the effective health-care program. J Clin Epidemiol. 2010;63(5):502–12.
Espinet Coll E, Nebreda Duran J, Lopez-Nava Breviere G, et al. Multicenter study on the safety of bariatric endoscopy. Rev Esp Enferm Dig. 2017;109(5):350–7.
de Jonge C, Rensen SS, Koek GH, et al. Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2013;11(11):1517–20.
de Jonge C, Rensen SS, D'Agnolo HM, et al. Six months of treatment with the endoscopic duodenal-jejunal bypass liner does not lead to decreased systemic inflammation in obese patients with type 2 diabetes. Obes Surg. 2014;24(2):337–41.
de Jonge C, Rensen SS, Verdam FJ, et al. Impact of duodenal-jejunal exclusion on satiety hormones. Obes Surg. 2016;26(3):672–8.
Betzel B, Koehestanie P, Homan J, et al. Changes in glycemic control and body weight after explantation of the duodenal-jejunal bypass liner. Gastrointest Endosc. 2017;85(2):409–15.
Escalona A, Yanez R, Pimentel F, et al. Initial human experience with restrictive duodenal-jejunal bypass liner for treatment of morbid obesity. Surg Obes Relat Dis. 2010;6(2):126–31.
Homs MY, Wahab PJ, Kuipers EJ, et al. Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial. Gastrointest Endosc. 2004;60(5):695–702.
Uitdehaag MJ, Siersema PD, Spaander MC, et al. A new fully covered stent with antimigration properties for the palliation of malignant dysphagia: a prospective cohort study. Gastrointest Endosc. 2010;71(3):600–5.
Kato H, Kawamoto H, Matsumoto K, et al. Outcome of self-expandable metallic stent deployment in patients with malignant gastroduodenal outlet obstruction and Niti-S and WallFlex comparison: a multicenter retrospective clinical study. J Dig Dis. 2016;17(8):518–25.
Sebastian S, Johnston S, Geoghegan T, et al. Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. Am J Gastroenterol. 2004;99(10):2051–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval and Informed Consent Statement
For this type of study, formal consent is not required. Therefore, informed consent does not apply.
Electronic Supplementary Material
Supplementary file 1
(DOCX 11 kb)
Supplementary file 2
Duodenal-jejunal bypass liner, consisting of the anchor and liner (PNG 9051 kb)
Supplementary file 3
(DOCX 90 kb)
Rights and permissions
About this article
Cite this article
Betzel, B., Drenth, J.P.H. & Siersema, P.D. Adverse Events of the Duodenal-Jejunal Bypass Liner: a Systematic Review. OBES SURG 28, 3669–3677 (2018). https://doi.org/10.1007/s11695-018-3441-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-018-3441-3